In this episode, Vic interviews Miriam Paramore, founder of RxUtility, about her extensive background in healthcare technology and her new venture aimed at improving medication affordability. They discuss the role of pharmaceutical copay coupons, highlighting the $10 billion in savings available to consumers annually, with specific mention of discounts for high-cost drugs like Ozempic and other GLP-1 medications, which can reduce the cost to as little as $25 per prescription. Miriam explains how RxUtility seeks to democratize these savings by integrating with existing healthcare systems, making it easier for patients to access and use coupons for prescription medications. The episode also covers RxUtility's business model, scaling plans, and its impact on patients and the healthcare industry.

Connect w/ Miriam Paramore

• Linkedin - https://www.linkedin.com/in/miriamparamore/
• RxUtility - https://rxutility.com/

00:00 Introduction and Background of Miriam Paramore

01:00 Early Career in Healthcare Tech

03:00 Transitioning into Management Consulting and Tech Solutions

06:00 Pharmaceutical Coupons and the $10 Billion Opportunity

10:00 The Scale of Pharmaceutical Savings Available

15:00 The Awareness and Distribution Problem in Healthcare Savings

20:00 The Creation of RxUtility and Its Mission

25:00 How RxUtility Partners with Healthcare Systems

30:00 Examples of Major Drug Savings: Ozempic and Farxiga

35:00 Impact of RxUtility on Patient Affordability and Adherence

HF Site

YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK